Study unravels the unique patterns of brain shrinkage in Alzheimer’s disease

FHS
October 4, 2024
11:32 pm

The way in which brains shrink in those who develop Alzheimer’s disease follows no specific or uniform pattern, finds a new study by researchers at UCL and Radboud University in the Netherlands.

Semaglutide cuts death rates from cardiovascular disease and COVID-19

Patients taking semaglutide injections are less likely to die of any cause, including from cardiovascular disease and infections like COVID-19, an international study led by

August 31, 2024

Fujitsu Partners with Paradigm for Enhanced Clinical Trials

What You Should Know: – Fujitsu today announced a series of initiatives aimed at attracting global clinical trials to Japan and addressing the issue of

August 26, 2024

Bristol Myers Squibb’s Reblozyl reinforces market share in first-line MDS Space – Pharmaceutical Technology

In the MDS space, Reblozyl was previously approved in 2020 as a treatment for very low to intermediate-risk MDS patients with ring sideroblasts or thrombocytosis

September 13, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.